This review article examines the potential of fecal microbiota transplantation (FMT) as a treatment for irritable bowel syndrome (IBS), a prevalent gastrointestinal disorder affecting approximately 11.2% of the global adult population. IBS is characterized by symptoms such as abdominal pain, bloating, and altered bowel habits, and is associated with dysbiosis—an
